Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Brain Oxygenation in Neurologic Intensive Care Unit : The NeurO2 Study

NCT04935866 is registered in ClinicalTrials.gov with CHU de Quebec-Universite Laval as lead sponsor.

NCT NCT04935866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04935866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Brain Oxygenation in Neurologic Intensive Care Unit : The NeurO2 Study
Lead sponsor
CHU de Quebec-Universite Laval
Phase
Observational
Overall status
Unknown status
Start date
May 7, 2021
Completion date
July 31, 2025
Enrollment
286 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, brain injuries, intensive care neurological disorder, near-infrared spectroscopy, subarachnoid hemorrhage, traumatic brain injury